Asia
Great Bay Bio, a leading biotechnology company dedicated to innovative biologics CMC (Chemistry Manufacturing and Controls) and development of biologics development big data platform, the board is pleased to announce the introduction of a new non-executive director, Mr. William Kung.
Singapore scientists and clinicians have discovered a promising use of antibodies to target a new cancer antigen, as an alternative for chemotherapy
Companies from across the globe share business and pipeline updates.
A new high-resolution approach using portable DNA sequencers provides a more complete genomic picture of antibiotic resistance in gut bacteria
TLC announced financial results for the second quarter ended June 30, 2019, and provided a business update.
Teva Pharmaceuticals, Endo Pharmaceuticals and Taikoku Pharma entered into settlement agreements with the State of California for a total of almost $70 million. The settlements were over non-competitive, inter-company deals that prevented cheaper drugs from entering the market.
The Tribune India has recently announced that the Department of Biotechnology will be training “unemployed youth in tools and techniques in the area of biotechnology within a period of three years.”
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced that Andrew Howden has been elected as non-executive Chairman of the Board.
A number of companies reported clinical trial data last week. Here’s a look.
SGX-listed Singapore eDevelopment Ltd is pleased to announce the results of clinical trials conducted on Laetose, a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc..
PRESS RELEASES